Knee hyaluronic acid injections market to hit $4.35 billion by 2030

The Business Research Company says the global knee hyaluronic acid injections market will rise from $3.17 billion in 2025 to $4.35 billion by 2030, driven by osteoarthritis, obesity and demand for minimally invasive joint care. North America led in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Knee hyaluronic acid injections are used to ease joint pain and improve mobility for patients with osteoarthritis and other knee problems. - The market’s growth signals rising demand for non-surgical and minimally invasive orthopedic treatments. - The category is also tied to broader public health trends, including obesity and aging populations, which are increasing knee-joint disease.

What happened: - The Business Research Company projected the global knee hyaluronic acid injections market will grow from $3.17 billion in 2025 to $3.37 billion in 2026. - The report said the market will reach $4.35 billion by 2030, reflecting a 6.6% compound annual growth rate. - The company released the outlook in its report, “Knee Hyaluronic Acid Injections Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035.” - A free sample of the report is available here. - The full report is available here.

The details: - The market’s historical growth has been driven by rising osteoarthritis prevalence, a larger elderly population, wider use of viscosupplementation therapies and more hospital-based orthopedic treatment. - The report said future growth will be supported by new hyaluronic acid formulations, higher healthcare spending on orthopedic care, more outpatient surgery facilities and interest in regenerative and biological treatments. - Key forecast-period trends include increased use of single-injection viscosupplementation, stronger preference for less invasive orthopedic treatments, more ambulatory care centers and ongoing clinical studies on hyaluronic acid molecular weights. - Knee hyaluronic acid injections work by supplementing natural hyaluronic acid in the joint, which improves lubrication and cushioning and reduces friction during movement. - The treatments are typically administered as a minimally invasive option and can help delay more invasive surgery. - Obesity is a major growth driver because excess body weight increases stress on the knee and worsens osteoarthritis. - The Office for Health Improvement and Disparities in the UK reported that 64.5% of adults age 18 and over in England were overweight or obese in 2023-2024, up from 64.0% the year before. - The World Health Organization said about 365 million people worldwide were affected by knee osteoarthritis in 2023.

Between the lines: - The forecast suggests the market is benefiting from a shift toward outpatient, lower-risk joint care rather than surgery-first treatment. - The report’s emphasis on single-injection products and molecular-weight studies points to competition around convenience and clinical performance. - North America’s lead in 2025 reflects stronger orthopedic infrastructure and awareness, while Asia-Pacific’s expected growth points to expanding healthcare investment and rising disease burden.

What's next: - The report expects the market to keep expanding through 2030 as osteoarthritis cases rise and more patients seek non-invasive care. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

The bottom line: - Knee hyaluronic acid injections are moving from a niche orthopedic option to a broader growth market, with aging, obesity and demand for minimally invasive treatment driving the long-term outlook.